University of Maryland Baltimore: First in Region Innovative Cell Therapy for Synovial Sarcoma
June 16, 2026
June 16, 2026
BALTIMORE, Maryland, June 16 -- The University of Maryland Baltimore campus issued the following news:
* * *
First in Region Innovative Cell Therapy for Synovial Sarcoma
Katie Ghiardi
The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) is the first in the Maryland, Delaware, Virginia, and Washington D.C. region to offer an innovative cell therapy treatment for patients with an advanced type of soft tissue cancer, known as . . .
* * *
First in Region Innovative Cell Therapy for Synovial Sarcoma
Katie Ghiardi
The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) is the first in the Maryland, Delaware, Virginia, and Washington D.C. region to offer an innovative cell therapy treatment for patients with an advanced type of soft tissue cancer, known as . . .